PH12020500246A1 - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- PH12020500246A1 PH12020500246A1 PH12020500246A PH12020500246A PH12020500246A1 PH 12020500246 A1 PH12020500246 A1 PH 12020500246A1 PH 12020500246 A PH12020500246 A PH 12020500246A PH 12020500246 A PH12020500246 A PH 12020500246A PH 12020500246 A1 PH12020500246 A1 PH 12020500246A1
- Authority
- PH
- Philippines
- Prior art keywords
- pharmaceutical compositions
- active ingredient
- compositions
- medicine
- buffer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762544346P | 2017-08-11 | 2017-08-11 | |
GBGB1713660.7A GB201713660D0 (en) | 2017-08-25 | 2017-08-25 | Pharmaceutical compositions |
PCT/GB2018/052292 WO2019030540A1 (en) | 2017-08-11 | 2018-08-13 | PHARMACEUTICAL COMPOSITIONS |
Publications (1)
Publication Number | Publication Date |
---|---|
PH12020500246A1 true PH12020500246A1 (en) | 2021-03-15 |
Family
ID=70976595
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH12020500246A PH12020500246A1 (en) | 2017-08-11 | 2020-02-03 | Pharmaceutical compositions |
Country Status (8)
Country | Link |
---|---|
CL (1) | CL2020000356A1 (es) |
CO (1) | CO2020002287A2 (es) |
EC (1) | ECSP20017939A (es) |
IL (1) | IL272428A (es) |
MX (1) | MX2020001356A (es) |
PH (1) | PH12020500246A1 (es) |
RU (1) | RU2020109955A (es) |
UA (1) | UA125537C2 (es) |
-
2018
- 2018-08-13 MX MX2020001356A patent/MX2020001356A/es unknown
- 2018-08-13 UA UAA202001624A patent/UA125537C2/uk unknown
- 2018-08-13 RU RU2020109955A patent/RU2020109955A/ru unknown
-
2020
- 2020-02-03 PH PH12020500246A patent/PH12020500246A1/en unknown
- 2020-02-03 IL IL272428A patent/IL272428A/en unknown
- 2020-02-11 CL CL2020000356A patent/CL2020000356A1/es unknown
- 2020-02-28 CO CONC2020/0002287A patent/CO2020002287A2/es unknown
- 2020-03-11 EC ECSENADI202017939A patent/ECSP20017939A/es unknown
Also Published As
Publication number | Publication date |
---|---|
MX2020001356A (es) | 2020-03-20 |
CO2020002287A2 (es) | 2020-06-09 |
RU2020109955A (ru) | 2021-09-14 |
IL272428A (en) | 2020-03-31 |
CL2020000356A1 (es) | 2020-06-19 |
ECSP20017939A (es) | 2020-04-22 |
RU2020109955A3 (es) | 2022-01-24 |
UA125537C2 (uk) | 2022-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NI201900041A (es) | 1, 2, 4-triazolonas 2, 4, 5-trisustituidas | |
MY196909A (en) | Boronic acid derivatives and therapeutic uses thereof | |
CO2020001244A2 (es) | Derivados de quinolina para tratar infecciones con helmintos | |
CR20170411A (es) | Composiciones farmacéuticas que comprenden n-(3,5-dimetoxifenil)-n-(1-metiletil)-n-[3-(1-metil-1h-pirazol-4-il-quin oxalin-6-il]etano-1,2-diamina | |
CR20210201A (es) | Nuevos compuestos antihelmínticos | |
MX368504B (es) | Derivados de amidas y sales farmaceuticamente aceptables de los mismos, método de preparación de los mismos y aplicación médica de los mismos. | |
PE20191650A1 (es) | Derivados de indolina sustituidos como inhibidores de la replicacion virica de dengue | |
TN2017000467A1 (en) | Amido-substituted cyclohexane derivatives | |
MX2018000285A (es) | Composicion para desobstruir la nariz congestionada que tiene actividad antiviral. | |
TN2019000204A1 (en) | Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same | |
CL2020002252A1 (es) | Formulación oftálmica. | |
MY163235A (en) | Pharmaceutical preparation containing pyridylaminoacetic acid compound | |
EA201591541A1 (ru) | Ингибиторы бета-секретазы 1 (bace 1) | |
PH12019502150A1 (en) | Compounds and methods for the treatment of parasitic diseases | |
PH12019500618A1 (en) | Pharmaceutical composition and method for treatment of non-alcoholic fatty liver disease | |
EP4234021A3 (en) | Pharmaceutical composition comprising an adenosine derivative for use in the prevention or treatment of diabetic nephropathy | |
MY197518A (en) | Preventive and/or therapeutic agent of immune disease | |
EA202190317A1 (ru) | Лекарственный препарат для наружного применения | |
PH12020500246A1 (en) | Pharmaceutical compositions | |
JOP20180071B1 (ar) | استخدام مشتقات أمينو ألكيل بنزوثيازبين | |
MX2023006235A (es) | Composiciones para administracion de farmacos y metodos de uso de las mismas. | |
MX2022006502A (es) | Composiciones farmaceuticas. | |
EA202191683A1 (ru) | Средство, содержащее 4-фенилбутират, для профилактики или лечения пресбиопии | |
RU2015137671A (ru) | Профилактическое или терапевтическое лекарственное средство для лечения запора | |
MX2016004464A (es) | Derivados novedosos de pradimicina para el tratamiento de enfermedades provocadas por kinetoplastidos. |